384 related articles for article (PubMed ID: 12360238)
21. Ethics and patentability in biotechnology.
Witek R
Sci Eng Ethics; 2005 Jan; 11(1):105-11. PubMed ID: 15727006
[TBL] [Abstract][Full Text] [Related]
22. Navigating the future(s) of biotech intellectual property.
Cukier KN
Nat Biotechnol; 2006 Mar; 24(3):249-51. PubMed ID: 16525371
[No Abstract] [Full Text] [Related]
23. Bio-patents, law and ethics. Critical analysis of the EU biotechnology directive.
Van Overwalle G
Rev Derecho Genoma Hum; 2003; (19):187-203. PubMed ID: 15032104
[No Abstract] [Full Text] [Related]
24. The attack of the clones: patent law and stem cell research.
Rimmer M
J Law Med; 2003 May; 10(4):488-505. PubMed ID: 12852321
[TBL] [Abstract][Full Text] [Related]
25. Licensing research tool patents.
Flattmann GJ; Kaplan JM
Nat Biotechnol; 2002 Sep; 20(9):945-7. PubMed ID: 12205511
[No Abstract] [Full Text] [Related]
26. Gene patents, health care policy and licensing schemes.
Caulfield T; von Tigerstrom B
Trends Biotechnol; 2006 Jun; 24(6):251-4. PubMed ID: 16621074
[TBL] [Abstract][Full Text] [Related]
27. Patenting and ethics--a dubious connection.
Crespi RS
J Pat Trademark Off Soc; 2003 Jan; 85(1):31-47. PubMed ID: 15212036
[No Abstract] [Full Text] [Related]
28. DNA patents and scientific discovery and innovation: assessing benefits and risks.
Resnik DB
Sci Eng Ethics; 2001 Jan; 7(1):29-62. PubMed ID: 11214383
[TBL] [Abstract][Full Text] [Related]
29. Innovations and intellectual property: the case of genomic patenting.
Jackson BA
J Policy Anal Manage; 2003; 22(1):5-25. PubMed ID: 12722760
[TBL] [Abstract][Full Text] [Related]
30. Public access versus proprietary rights in genomic information: what is the proper role of intellectual property rights?
Mueller JM
J Health Care Law Policy; 2003; 6(2):222-40. PubMed ID: 15017961
[No Abstract] [Full Text] [Related]
31. The gene patenting controversy: a convergence of law, economic interests, and ethics.
Kevles DJ; Berkowitz A
Brooklyn Law Rev; 2001; 67(1):233-48. PubMed ID: 12645549
[No Abstract] [Full Text] [Related]
32. Are DNA patents bad for medicine?
Resnik DB
Health Policy; 2003 Aug; 65(2):181-97. PubMed ID: 12849916
[TBL] [Abstract][Full Text] [Related]
33. Patents and innovation in cancer therapeutics: lessons from CellPro.
Bar-Shalom A; Cook-Deegan R
Milbank Q; 2002; 80(4):637-76, iii-iv. PubMed ID: 12532643
[TBL] [Abstract][Full Text] [Related]
34. [Patentability of living material: public health concerns (1/2)].
Manuel C; Hairion D; Antoniotti S; Lafon C; Siméoni MC; Auquier P
Presse Med; 2002 Oct; 31(34):1591-5. PubMed ID: 12426975
[TBL] [Abstract][Full Text] [Related]
35. The unexamined assumptions of intellectual property: adopting an evaluative approach to patenting biotechnological innovation.
Gold ER; Adams W; Castle D; de Langavant GC; Cloutier LM; Daar AS; Glass A; Smith PJ; Bernier L
Public Aff Q; 2004 Oct; 18(4):299-344. PubMed ID: 15812959
[No Abstract] [Full Text] [Related]
36. Patentability of life and ethics.
Lenoir N
C R Biol; 2003; 326(10-11):1127-34. PubMed ID: 14744124
[TBL] [Abstract][Full Text] [Related]
37. Patenting human genes: when economic interests trump logic and ethics.
Kluge EH
Health Care Anal; 2003 Jun; 11(2):119-30. PubMed ID: 14567475
[TBL] [Abstract][Full Text] [Related]
38. Intellectual Property in Genetic Material.
Gatley I
J Bioeth Inq; 2015 Dec; 12(4):561-4. PubMed ID: 26691916
[No Abstract] [Full Text] [Related]
39. Patents, innovation, and privatization: Commentary on: "Data management in academic settings: an intellectual property perspective".
Albin RC
Sci Eng Ethics; 2010 Dec; 16(4):777-81. PubMed ID: 20882419
[TBL] [Abstract][Full Text] [Related]
40. Should there be property rights in genes?
Dworkin G
Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1077-86. PubMed ID: 9304674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
